The term "biobanking" is sometimes misused to refer to any collection of human biological materials (biospecimens), regardless of ethical or regulatory restrictions or the uniformity of various tissue collecting procedures. Large collections of biospecimens connected to important personal and health information (health records, family history, lifestyle, genetic information) are stored primarily for use in health and medical research, according to a suitable definition of biobanks. Furthermore, the International Organization for Standardization emphasizes the concept of biobanks as legal entities driving the acquisition and storage process, as well as some or all of the activities related to collection, preparation, preservation, testing, analysis, and distribution of defined biological material, as well as related information and data (ISO 20387:2018). It's impossible to identify all of a biobank's distinguishing characteristics because they all have diverse histories and goals. Furthermore, biobanks are concerned with the public good rather than individual rewards for participants, and seek to give a public benefit for future generations through the translation and application of research findings. It's critical to recognize that biological samples are "pseudonymized" rather than completely "anonymized"; this is crucial for providing feedback to sample owners, retrieving valuable information, and reuniting them with their specimens
Title : A revolution or surrender: The success and failures of tissue engineering and regenerative medicine
Thomas J Webster, Hebei University of Technology, United States
Title : Electroactive polymers as artificial muscle materials: New opportunities for biomaterials and tissue engineering
Federico Carpi, University of Florence, Italy
Title : The development of an open-source low-cost 3d “micro”-bioprinter
Lauren R Harrison, McGill University, Canada
Title : Dynamic compression pressure regulates chondrogenic potential and immunologic characteristics of nucleus pulposus progenitor cells in the 3D cultured porous gelatin scaffold
Yu Wei Kung, Ming Chi University of Technology, Taiwan
Title : Biodegradable ultrathin nanofibrous membranes for retinal tissue engineering
Hana Studenovska, Institute of Macromolecular Chemistry, Czech Republic
Title : Achieving charge variant profile of innovator molecule during development of monoclonal antibody-based biosimilars – use of media components
Neelesh gangwar, Indian Institute of Technology, Delhi, India